Mrs Andi D Neuhofel, PHARMD | |
346 Maine St., Lawrence, KS 66044 | |
(785) 727-4131 | |
Not Available |
Full Name | Mrs Andi D Neuhofel |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 346 Maine St., Lawrence, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154691806 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 1-14181 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Andi D Neuhofel, PHARMD 3202 Nottingham Ct., Lawrence, KS 66049 Ph: (785) 393-8515 | Mrs Andi D Neuhofel, PHARMD 346 Maine St., Lawrence, KS 66044 Ph: (785) 727-4131 |
News Archive
Allied Management Group – Special Investigation Unit (AMG-SIU) will be speaking at the National Association for Medicaid Program Integrity (NAMPI) conference later this month to educate members on the essentials of audit preparation. AMG-SIU began as an audit firm providing consulting services to the health care industry more than 35 years ago. The company is now actively working with health groups across the U.S. to prepare for MIP audits in addition to their other services.
The delivery of chemical messenger (neurotransmitter) receptors to the junctions between nerve cells (synapses) is crucial to cognitive processes such as memory.
Baxter International Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) granted its "positive opinion" for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. This positive opinion confirms the acceptability of Baxter's regulatory submission to obtain final marketing authorization and licensure of the product.
A report by the National Cancer Director, Professor Mike Richards, shows unacceptably high variations across the country in the uptake of cancer drugs approved by the National Institute for Clinical Excellence (NICE).
Cancer Research Technology (CRT), the oncology-focused development and commercialisation company wholly owned by Cancer Research UK, today announce that they have entered into an agreement with Hammersmith Hospitals NHS Trust (London, UK) to develop Phased Array High-Intensity Focused Ultrasound (HIFU) for the treatment of cancer.
› Verified 1 days ago
Jakob Ready, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3421 W 6th St, Lawrence, KS 66049 Phone: 785-841-9000 | |
Carrie Lynn Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2336 Ridge Ct, Ste C, Lawrence, KS 66046 Phone: 785-841-1950 Fax: 785-841-1051 | |
William J Anderson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1410 Kasold Dr, Ste A16, Lawrence, KS 66049 Phone: 785-843-8555 Fax: 785-843-0645 | |
Nikita Gandhi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2300 Iowa St, Lawrence, KS 66046 Phone: 785-832-1112 | |
Dr. Michelle Wessling, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 325 Maine St, Lawrence, KS 66044 Phone: 785-505-5127 | |
Bridget Ellen Gillespie, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 W 23rd Street, Lawrence, KS 66046 Phone: 785-832-8388 | |
Lauren Dick, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1016 Lakecrest Rd, Lawrence, KS 66049 Phone: 785-218-9287 |